Patent · US Expired

Kappa agonist compounds, pharmaceutical formulations and method of prevention and treatment of pruritus therewith

US6960612B2 · kind B2 · utility

0Cited by

40References

4Claims

0Family size

Assignee

Adolor Corporation · US

Inventors

Lawrence I. Kruse · Haddonfield, US
An-Chih Chang · Phoenixville, US
Diane L. DeHaven-Hudkins · Chester Springs, US
John J. Farrar · Chester Springs, US
Forrest Gaul · Douglassville, US
Virendra Kumar · Paoli, US
Michael Anthony Marella · Philadelphia, US
Alan L. Maycock · Malvern, US
Wei Zhang · San Diego, US

Key dates

Filing date	Jun 5, 2003
Grant date	Nov 1, 2005
Priority date	—
Expiry date	Oct 10, 2023

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Methods for prevention or treatment of pruritus are provided. The methods comprise administering to a patient an effective amount of a kappa opioid receptor agonist compound. The involved kappa opioid receptor agonist compounds are of the type represented by the following formula III

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.